Growth Projects Lead Amid Reduced Capex

Why It Matters

The shift toward growth‑focused, AI‑centric investments signals a strategic pivot that could reshape hospital profitability and patient experience, while forcing vendors to prove measurable value. It also highlights mounting fiscal pressure on health systems, influencing industry consolidation and technology adoption rates.

Key Takeaways

• 46% of execs prioritize revenue growth projects for 2026
• AI clinical tools planned by 57% of health systems, up from 19%
• Capital spending cuts: 19% expect >20% reduction, 22% expect 10% cut
• Care delivery innovation priority falls to 30% in 2026
• ROI becomes top purchasing factor for 77% of respondents

Pulse Analysis

Health systems are tightening their capital belts as labor, supply and borrowing costs squeeze margins, prompting 19% of executives to slash budgets by more than 20% for 2026. Yet the same fiscal restraint is fueling a strategic reallocation toward revenue‑generating projects, with nearly half of C‑suite leaders targeting new markets and patient acquisition. This pivot reflects broader policy shifts that push care out of traditional hospital walls and toward outpatient and consumer‑centric models, forcing administrators to prioritize growth over pure clinical innovation.

Artificial intelligence is emerging as the flagship technology in this new capital landscape. Over half of surveyed health systems plan to invest in AI‑based clinical tools, a jump from just 19% two years ago, driven by evidence that AI scribes can shave minutes off physician documentation and add nearly half a visit per week. However, executives caution that technology alone won’t deliver success; the lessons of the costly, decades‑long EHR rollout underscore the need for robust governance, data quality, and workflow redesign. Without these foundations, AI deployments risk repeating past failures despite their speed and promise.

The heightened emphasis on ROI reshapes vendor negotiations, with predictable pricing models such as monthly or annual contracts gaining favor over performance‑based deals. As 77% of leaders rank anticipated financial return above all else, vendors must articulate clear business cases, integrate seamlessly with existing EHRs, and demonstrate cost efficiencies. This ROI‑centric mindset is likely to accelerate the adoption of solutions that can quickly translate into measurable savings, while marginalizing speculative innovations that lack a solid economic rationale.